Search results
Health Care Stocks Decline As Insurance Weighs -- Health Care Roundup
Market Watch· 4 hours agoShares of major health insurers dropped after UnitedHealth Group executives forecast a "disturbance" in its Medicaid business and addressed patients' utilization of healthcare services at an ...
Exclusive | Merck Nears $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 24 hours agoSuch an acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the...
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 29%?
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights The projected fair value for Merck KGaA is €236 based on 2 Stage Free Cash Flow to...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 4 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 1 day agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 10 hours agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 13 hours agoJeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant ...
Dow Jones Sells Off 400 Points Ahead Of Fed Report; Nvidia Falls From Record Highs
Investor's Business Daily· 11 hours agoStock Market Today: Best Stocks To Watch Monday.com, Netflix and Crocs — plus Dow Jones components...
Merck nears $1.3 bln takeover of Eyebiotech- WSJ By Investing.com
Investing.com· 23 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 2 days agoMerck & Co (NYSE:MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...